Unit 4: Physico‑Chemical Principles

Unit 4: Physico-Chemical Principles

Solutions

Definition and Fundamental Concepts

A solution is defined as a chemically and physically homogeneous mixture of two or more substances . The term homogeneous implies that the mixture is uniform, meaning all parts are identical and when subjected to routine chemical and physical analysis, they test the same.

Components of Solutions

• Solute: The component that is dissolved (present in smaller amount)
• Solvent: The component that does the dissolving (present in larger amount)
• Binary solution: A mixture containing only two components

Classification of Solutions by Physical States

Classification of Pharmaceutical Solutions by Route of Administration

Advantages of Solutions as Dosage Forms

• Faster onset of activity compared to solid dosage forms
• Suitable for children and elderly patients with swallowing difficulties
• Homogeneous and always uniform
• Flexible dosing adjustments
• Uniform distribution of drug

---

Concentration Expressions

Percentage Expressions

Molar Expressions

Parts Expressions

• Parts per million (ppm): mg solute / kg solution or mg/L for dilute aqueous solutions
• Parts per billion (ppb): μg solute / kg solution

Conversion Between Concentration Units

Converting between different concentration expressions requires knowledge of:

• Density of solution
• Molecular weight of solute
• Relationship between mass and volume

---

Ideal and Real Solutions

Ideal Solutions

An ideal solution is one that obeys Raoult's law throughout the entire concentration range. In ideal solutions:

• The intermolecular forces between solute-solute (A-A), solvent-solvent (B-B), and solute-solvent (A-B) are identical
• No volume change occurs upon mixing (ΔV_mix = 0)
• No enthalpy change occurs upon mixing (ΔH_mix = 0)
• The vapor pressure follows Raoult's law: P = P⁰ × X

where P is partial vapor pressure of component, P⁰ is vapor pressure of pure component, and X is mole fraction.

Raoult's Law For a solution containing volatile components, the partial vapor pressure of each component is equal to the vapor pressure of the pure component multiplied by its mole fraction in the solution:

P_A = P_A⁰ × X_A P_B = P_B⁰ × X_B

Total vapor pressure P_total = P_A + P_B = P_A⁰ X_A + P_B⁰ X_B

Real Solutions

Real solutions deviate from Raoult's law due to differences in intermolecular forces:

Henry's Law For dilute real solutions, the partial pressure of a volatile solute is proportional to its mole fraction:

P = K_H × X

where K_H is Henry's law constant (specific for each solute-solvent system). Henry's law applies to the solute in dilute solutions, while Raoult's law applies to the solvent.

---

Colligative Properties

Definition

Colligative properties are properties of solutions that depend only on the number of solute particles (concentration) and not on the nature or chemical identity of the solute. These properties arise from the lowering of solvent chemical potential by the presence of solute.

The Four Colligative Properties

where:

• X_solute = mole fraction of solute
• K_b = molal boiling point elevation constant (characteristic of solvent)
• K_f = molal freezing point depression constant (characteristic of solvent)
• m = molality of solution
• i = van't Hoff factor (accounts for dissociation/association)
• M = molarity
• R = gas constant (0.0821 L·atm/mol·K)
• T = absolute temperature (K)

van't Hoff Factor (i)

The van't Hoff factor accounts for the number of particles produced per formula unit of solute:

Applications of Colligative Properties in Pharmacy

---

Solubility and Solubilization

Definition and Concepts

Solubility Defined

Solubility is the maximum amount of solute that can dissolve in a given amount of solvent at a specified temperature, forming a homogeneous mixture . Equilibrium solubility is the point at which the dissolution rate equals the precipitation rate, representing the maximum amount of substance that can be dissolved in a stable equilibrium .

Quantitative Solubility Classification (USP/BP)

Biopharmaceutics Classification System (BCS)

The BCS categorizes APIs based on solubility and permeability to predict in vivo performance :

Approximately 30-40% of marketed drugs and 70-90% of drugs in development are poorly soluble (BCS Class II and IV) .

Developability Classification System (DCS)

The DCS further differentiates Class II drugs :

• DCS Class IIa (dissolution rate-limited): Dissolution rate too slow for API to dissolve during transit through small intestine
• DCS Class IIb (solubility-limited): Solubility too low for required amount to dissolve in available GI fluid volume

---

Mechanism of Solubilization

The Solubilization Process

Solubilization involves three distinct steps :

1. Separation: A solute molecule must be separated from the solid state by breaking solute-solute bonds (requires energy input)
2. Gap creation: A cavity or gap must be created within the solvent to accommodate the solute molecule
3. Incorporation: The solute molecule must be incorporated into the solvent through solute-solvent interactions

Thermodynamics of Solubilization

The solubilization of a crystalline organic compound in an aqueous medium involves two distinct thermodynamic steps :

1. Crystal lattice breaking: Breaking the crystal lattice into free molecules (endothermic, requires energy)
2. Solvation: Solvating these free molecules by the aqueous medium (exothermic, releases energy)

This can be quantitatively represented as: log X = log X_ideal - log γ

where:

• X = observed (mole fraction) solubility
• X_ideal = ideal solubility (determined by crystal lattice energy, same regardless of solvent)
• γ = activity coefficient of solute in the solvent medium (reflects deviation from ideality)

The Hydrophobic Effect

Aqueous solutions of organic compounds are highly nonideal because water-water interactions are much stronger than solute-solute or solute-water interactions . The tendency of nonpolar groups to aggregate in aqueous media (the "hydrophobic effect") primarily results from the strong attractive forces between water molecules rather than those between nonpolar solutes.

• Each water molecule can form up to four hydrogen bonds with neighboring molecules
• To solubilize a solute, the hydrogen bond network must be disrupted or distorted
• Ionic/polar solutes form strong ion-dipole interactions that compensate for this disruption
• Nonpolar solutes form weak interactions insufficient to compensate, making them difficult to solubilize

---

Factors Affecting Solubility

1. Nature of Solute and Solvent: "Like Dissolves Like"

2. Temperature

3. Pressure

• Significant effect only on gases in liquids
• Henry's law: C = k × P (solubility proportional to partial pressure)
• Minimal effect on solids and liquids

4. pH and pKa (for ionizable drugs)

The pH of the medium affects the ionization state of weak acids and bases, dramatically influencing solubility.

For weak acids: % ionized = 100 / [1 + 10^(pKa - pH)] For weak bases: % ionized = 100 / [1 + 10^(pH - pKa)]

5. Particle Size

For particles < 1 μm, solubility increases with decreasing particle size according to the Ostwald-Freundlich equation:

log (S/S₀) = (2γV) / (2.303 RT r)

where:

• S = solubility of small particles
• S₀ = solubility of large particles
• γ = interfacial tension
• V = molar volume
• r = particle radius

6. Polymorphism

Different polymorphic forms of the same drug exhibit different solubilities. The most stable polymorph (lowest free energy) has the lowest solubility .

7. Complexation

Formation of soluble complexes can increase apparent solubility:

• Cyclodextrin inclusion complexes
• Metal-ion complexes
• Molecular complexes

8. Cosolvents

Addition of water-miscible solvents (ethanol, propylene glycol, glycerin, PEG) can significantly increase solubility of poorly water-soluble drugs.

---

Solubilization Techniques

Strategies for Enhancing Solubility

Solid Dispersions

Solid dispersions consist of a hydrophobic drug dispersed in a hydrophilic carrier matrix. Recent advances include biodendrimeric solid dispersions (BDSD) using modified dendrimer-like biopolymers that create a favorable nonpolar microenvironment for solubilization .

---

Dissolution and Permeation

Dissolution: Definition and Concepts

Definition

Dissolution is the process by which a solid solute enters into solution. For pharmaceutical dosage forms, dissolution refers to the rate and extent at which the active pharmaceutical ingredient (API) dissolves in the dissolution medium under specified conditions.

Significance of Dissolution

• Critical for drug absorption and bioavailability
• Quality control parameter for solid dosage forms
• Predictor of in vivo performance (with established IVIVC)
• Tool for formulation development and optimization

---

Noyes-Whitney Equation

The Fundamental Equation

The Noyes-Whitney equation (1897) describes the rate of dissolution of a solid in a liquid:

dC/dt = k × (C_s - C)

where:

• dC/dt = dissolution rate (rate of change of concentration in solution)
• k = dissolution rate constant
• C_s = saturation solubility of the drug (concentration at the solid surface)
• C = concentration of drug in the bulk solution at time t
• (C_s - C) = concentration gradient

Modified Noyes-Whitney Equation (Nernst-Brunner)

The equation was later modified to incorporate diffusion layer theory:

dC/dt = (D × A × (C_s - C)) / (h × V)

where:

• D = diffusion coefficient of the drug
• A = surface area of the dissolving solid
• h = thickness of the diffusion layer (unstirred boundary layer)
• V = volume of the dissolution medium

Key Parameters Affecting Dissolution Rate

Sink Conditions

Sink conditions exist when the drug concentration in the bulk solution (C) is maintained at less than 10-20% of saturation solubility (C_s). Under sink conditions, C_s - C ≈ C_s, and the dissolution rate becomes essentially constant:

dC/dt = (D × A × C_s) / (h × V)

Model-Free Noyes-Whitney Integral Equation

Recent advances have proposed a model-free Noyes-Whitney integral equation to characterize dissolution profiles without assuming specific models . This approach allows for the analysis of complicated heterogeneous dissolution processes, particularly when disintegration occurs simultaneously with dissolution.

---

Factors Affecting Dissolution

1. Physicochemical Factors Related to the Drug

2. Formulation Factors

3. Medium-Related Factors

4. Hydrodynamic Factors

---

Permeation: Definition and Concepts

Definition

Permeation is the process by which drug molecules move across biological membranes. It is a critical determinant of drug absorption, distribution, and elimination.

Mechanisms of Drug Permeation

Fick's Laws of Diffusion

First Law (Steady State): J = -D × (dC/dx)

where:

• J = flux (amount crossing unit area per unit time)
• D = diffusion coefficient
• dC/dx = concentration gradient

Second Law (Non-Steady State): dC/dt = D × (d²C/dx²)

Permeability Coefficient

The permeability coefficient (P) combines diffusivity and partitioning:

P = (D × K) / h

where:

• K = partition coefficient between membrane and aqueous phase
• h = membrane thickness

The flux can then be expressed as: J = P × (C₁ - C₂)

---

Factors Affecting Permeation

1. Physicochemical Properties of the Drug

pH-Partition Hypothesis

The pH-partition hypothesis states that:

• The unionized form of a drug is preferentially absorbed
• The absorption rate depends on the fraction of unionized drug at the absorption site
• The lipid-water partition coefficient of the unionized form determines its membrane permeability

For weak acids: Maximum absorption in acidic environments (stomach) For weak bases: Maximum absorption in basic environments (intestine)

2. Membrane Factors

3. Formulation Factors

4. Biological Factors

---

Polymorphism

Basic Concepts and Terminology

Definition

Polymorphism (or crystal polymorphism) is the ability of a chemical compound in the solid state to exist in different crystalline forms having the same chemical composition . The difference in internal crystal structure can be attributed to differences in molecule packing arrangements and/or different molecular conformations.

Related Terms

Hydrate Classification

Hydrates can be classified into three categories :

• Class I: Water molecules exist at isolated sites
• Class II: Channel hydrates (water in channels throughout crystal structure)
• Class III: Ion-coordinated site hydrates (water forms ion-water bonds stronger than hydrogen bonds)

---

Lattice Structure and Crystal Forms

Crystal Lattice

A crystal lattice is a three-dimensional arrangement of atoms, ions, or molecules in a repeating pattern. The smallest repeating unit is called the unit cell.

Crystal Habit vs. Crystal Form

• Crystal form (polymorph): Different internal crystal structure (different unit cell arrangement)
• Crystal habit: Different external shape of crystals with the same internal structure

Variations in crystal habit may indicate the presence of polymorphism but do not necessarily prove different polymorphic forms.

Factors Influencing Polymorph Formation

---

Thermodynamic Relationships

Stability Relationships

• The form with the lowest free energy is the most thermodynamically stable at a given temperature and pressure
• All other forms are in a metastable state
• At standard temperature and pressure, a metastable form may remain unchanged or may transform to a more stable form

Enantiotropic vs. Monotropic Systems

Physicochemical Properties Affected by Polymorphism

---

Significance in Pharmaceuticals

Why Polymorphism Matters

1. Bioavailability Impact: Different polymorphs have different solubilities and dissolution rates, directly affecting drug absorption and therapeutic efficacy

2. Stability Concerns: Transformation to a more stable polymorph during storage can alter product performance

3. Manufacturing Consistency: Different polymorphs may have different flow properties, compressibility, and processing characteristics

4. Regulatory Requirements: Control of polymorphic form may be required in regulatory submissions

5. Patent Considerations: Novel polymorphs can extend patent protection

When Polymorphism is Critical

Case Study: False Negative in Biological Testing

A recent case study demonstrated how unexpected crystallinity can lead to false negative results in biological testing . Two samples of the same tyrosine kinase inhibitor (compound 1) appeared similar but produced contradictory biological results:

X-ray powder diffraction confirmed that PB1 was microcrystalline while IQS016 was primarily amorphous/partially crystalline. DSC analysis revealed a 16°C difference in onset melting temperature. The crystalline PB1 sample had lower solubility, explaining its lack of biological activity .

This case highlights the critical importance of characterizing solid-state form before biological testing, particularly in early drug discovery.

---

Amorphous vs. Crystalline Solids

Comparison of Properties

Advantages and Challenges of Amorphous Forms

Detection and Characterization of Amorphous Content

• X-ray powder diffraction (absence of sharp peaks)
• Differential scanning calorimetry (glass transition temperature)
• Dynamic vapor sorption (increased moisture uptake)
• Solid-state NMR

---

Role in Dissolution

Mechanism of Dissolution Rate Differences

The higher dissolution rate of metastable polymorphs and amorphous forms is due to:

• Higher free energy (greater thermodynamic activity)
• Lower crystal lattice energy barrier to dissolution
• Potentially better wettability

Practical Implications

Control Strategies

The International Pharmacopoeia recommends :

• Control of polymorphic form when bioavailability, stability, or processability are impacted
• Use of specific analytical techniques (X-ray diffraction, DSC, solid-state NMR)
• Monitoring during processing and in finished product when critical
• Understanding thermodynamic relationships between forms

---

Analytical Techniques for Polymorphism

**Common Techniques for Studying Polymorphs **

Technique Selection Considerations

• Multiple complementary techniques are often necessary
• XRPD is currently regarded as providing definitive evidence of polymorphism
• Sample preparation must avoid inducing transformations (heat, pressure, grinding)

---

Summary Tables

Table 1: Solution Types and Concentration Expressions

---

Table 2: Colligative Properties and Pharmaceutical Applications

---

Table 3: Factors Affecting Solubility and Dissolution

---

Table 4: Noyes-Whitney Equation Parameters

---

Table 5: Permeation Mechanisms and Characteristics

---

Table 6: Polymorphism Classification and Properties

---

References

1. Sinko, P. J. (2023). Martin's Physical Pharmacy and Pharmaceutical Sciences. Wolters Kluwer Health. (Chapters on Solutions, Solubility, Dissolution, and Solid-State Properties)

2. Taylor, K., & Aulton, M. E. (2021). Aulton's Pharmaceutics: The Design and Manufacture of Medicines. Elsevier. (Chapters on Drug Solubility, Dissolution, and Permeation)

3. Filippa, M. (2023). Physical Pharmacy. In Advanced Pharmacy. Bentham Science Publishers.

4. Solubilization of poorly water-soluble drugs through partition/association equilibrium: Thermodynamic insights using isothermal titration calorimetry. (2025). Journal of Pharmaceutical Sciences.

5. Hattori, Y., Haruna, Y., & Otsuka, M. (2013). Dissolution process analysis using model-free Noyes-Whitney integral equation. Colloids and Surfaces B: Biointerfaces, 102, 227-231.

6. The International Pharmacopoeia Twelfth Edition. (2024). Supplementary information: Notes for guidance: Polymorphism. World Health Organization.

7. Sandmann, B. J., Al-Achi, A., & Greenwood, R. (2023). Physical Properties of Solutions. In AccessPharmacy. McGraw-Hill Medical.

8. Improving API Solubility - by Merck. (2023). Pharma Excipients.

9. When Unsuspected Crystallinity Ruins Biological Testing in Early Discovery: A Case Study. (2024). Pharmaceuticals, 17(3), 284.

10. Alam, M. M., & Alam, M. T. (2023). Physical and Analytical Chemistry for Pharmacy Students. Springer.

---

Recommended Textbooks for Further Reading:

• Sinko, P. J. (2023). Martin's Physical Pharmacy and Pharmaceutical Sciences. Wolters Kluwer Health. (Comprehensive coverage of all Unit 4 topics)
• Taylor, K., & Aulton, M. E. (2021). Aulton's Pharmaceutics: The Design and Manufacture of Medicines. Elsevier. (Excellent integration of theory and practice)
• British Pharmacopoeia Commission. (2024). British Pharmacopoeia 2025. (Official standards for pharmaceutical substances)
• United States Pharmacopeial Convention. (2024). USP-NF 2024. (Official compendia standards including dissolution testing)